[Congressional Record Volume 167, Number 145 (Tuesday, August 10, 2021)]
[Senate]
[Pages S6398-S6399]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3697. Ms. HASSAN submitted an amendment intended to be proposed by

[[Page S6399]]

her to the concurrent resolution S. Con. Res. 14, setting forth the 
congressional budget for the United States Government for fiscal year 
2022 and setting forth the appropriate budgetary levels for fiscal 
years 2023 through 2031; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. RESERVE FUND RELATING TO PROTECTING MEDICARE 
                   BENEFICIARIES FROM INCREASES IN DRUG SPENDING.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     protecting Medicare beneficiaries from increases in drug 
     spending, which may include ensuring that any individual 
     policy that increases Medicare beneficiary premiums or 
     taxpayer spending on pharmaceuticals be fully offset by 
     additional rebates from drug manufacturers to the Medicare 
     program, by the amounts provided in such legislation for 
     those purposes, provided that such legislation would not 
     increase the deficit over the period of the total of fiscal 
     years 2022 through 2031.
                                 ______